Home CellKey

CellKey

In operation
-
Glycoprotein Biomarker Developer
Basic
Enterprise Profile

Basic Information

CellKey combines innovative glycoprotein analysis technology with artificial intelligence to develop optimal biomarkers for disease diagnosis and treatment, aiming to contribute to human health. CellKey contributes to extending life through innovative biotechnology research and development.
CELLKEY Inc.
SouthKorea
less than 15 people
January 01, 2003
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production Biological Product Manufacturing
Technology
Artificial Intelligence Protein Technology
Concept
Tumor
Application Scenarios
Innovative Drugs Biological Products AI+Pharmaceuticals